NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Rowley Law PLLC is
investigating potential securities law violations by Intersect ENT,
Inc. (NASDAQ: XENT) and its board of directors concerning the
proposed acquisition of the company by Medtronic plc (NYSE: MDT).
Stockholders will receive $28.25 for
each share of Intersect ENT stock that they hold. The transaction
is valued at approximately $1.1
billion and is expected to close by April 2022.
If you are a stockholder of Intersect ENT, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/xent/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-intersect-ent-inc-301351224.html
SOURCE Rowley Law PLLC